JP2005502687A - β−ラクタマーゼ阻害剤としての７−アルキリデン−３−置換型−３−セフェム−４−カルボキシラート - Google Patents

β−ラクタマーゼ阻害剤としての７−アルキリデン−３−置換型−３−セフェム−４−カルボキシラート Download PDF

Info

Publication number
JP2005502687A
JP2005502687A JP2003525002A JP2003525002A JP2005502687A JP 2005502687 A JP2005502687 A JP 2005502687A JP 2003525002 A JP2003525002 A JP 2003525002A JP 2003525002 A JP2003525002 A JP 2003525002A JP 2005502687 A JP2005502687 A JP 2005502687A
Authority
JP
Japan
Prior art keywords
compound
alkyl
aryl
hydrogen
alkanoyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003525002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502687A5 (enExample
Inventor
バイナク，ジョン，ディー
ヴォゲティ，ラクシュミナラヤナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AlamX LLC
Original Assignee
AlamX LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AlamX LLC filed Critical AlamX LLC
Publication of JP2005502687A publication Critical patent/JP2005502687A/ja
Publication of JP2005502687A5 publication Critical patent/JP2005502687A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
JP2003525002A 2001-07-24 2002-07-24 β−ラクタマーゼ阻害剤としての７−アルキリデン−３−置換型−３−セフェム−４−カルボキシラート Pending JP2005502687A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30740301P 2001-07-24 2001-07-24
PCT/US2002/023613 WO2003020732A2 (en) 2001-07-24 2002-07-24 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors.

Publications (2)

Publication Number Publication Date
JP2005502687A true JP2005502687A (ja) 2005-01-27
JP2005502687A5 JP2005502687A5 (enExample) 2006-01-12

Family

ID=23189607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003525002A Pending JP2005502687A (ja) 2001-07-24 2002-07-24 β−ラクタマーゼ阻害剤としての７−アルキリデン−３−置換型−３−セフェム−４−カルボキシラート

Country Status (9)

Country Link
US (2) US6916801B2 (enExample)
EP (1) EP1430060B1 (enExample)
JP (1) JP2005502687A (enExample)
AT (1) ATE339424T1 (enExample)
AU (1) AU2002353768A1 (enExample)
CA (1) CA2454413A1 (enExample)
DE (1) DE60214740T2 (enExample)
ES (1) ES2272795T3 (enExample)
WO (1) WO2003020732A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509351A (ja) * 2008-11-20 2012-04-19 プレジデント アンド フェローズ オブ ハーバード カレッジ 有機化合物のフッ素化

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219085T1 (de) 1997-12-29 2002-06-15 Res Corp Technologies Inc 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren
US6407091B1 (en) 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
CA2454413A1 (en) * 2001-07-24 2003-03-13 Alamx, L.L.C. 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors
WO2003087105A1 (en) 2002-04-04 2003-10-23 Alamx, L.L.C. INHIBITORS OF SERINE AND METALLO-ß-LACTAMASES
US7833998B2 (en) * 2003-08-25 2010-11-16 Revaax Pharmaceuticals, Llc Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions
US8299051B2 (en) * 2008-05-13 2012-10-30 Southern Methodist University Beta-lactamase inhibitory compounds
WO2012142162A2 (en) 2011-04-12 2012-10-18 President And Fellows Of Harvard College Fluorination of organic compounds
WO2014052622A1 (en) 2012-09-26 2014-04-03 President And Fellows Of Harvard College Nickel fluorinating complexes and uses thereof
CN103387584B (zh) * 2013-07-17 2015-02-25 盐城开元医药化工有限公司 一种7-氨基-3-氯-3-头孢环-4-羧酸的合成方法
US10759764B2 (en) 2013-10-18 2020-09-01 President And Fellows Of Harvard College Fluorination of organic compounds
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053468A (en) 1976-02-25 1977-10-11 Smithkline Corporation Process for preparing 7-oxo cephalosporins and 6-oxo penicillins
IT1193922B (it) 1979-02-24 1988-08-31 Erba Farmitalia Agenti antibatterici ed inibitori di beta -lattamasi e loro preparazione
ZA80993B (en) 1979-02-24 1981-02-25 Erba Farmitalia -lactam-containing antibacterial agents and -lactamase inhibitors and preparation thereof
GB2076812A (en) 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
US4369312A (en) 1980-07-04 1983-01-18 Fujisawa Pharmaceutical Co., Ltd. Method of producing oxo-containing azetidinone compounds
CA1180005A (en) 1980-10-24 1984-12-27 Solange Adam-Molina .beta.-LACTAMS
ZA826687B (en) 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
EP0150984B1 (en) 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
DD234015A5 (de) 1984-01-30 1986-03-19 Pfizer Verfahren zur herstellung von 6-(subst.)-methylen-penicillan-und 6-(subst.)-hydroxymethyl-penicillansaeure und deren derivaten
US4826833A (en) 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
EP0170192B1 (en) 1984-07-30 1992-05-13 Merck & Co. Inc. Penicillin derivatives as anti-inflammatory and antidegenerative agents
US4861768A (en) 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
JPS62198687A (ja) 1986-02-27 1987-09-02 Taiho Yakuhin Kogyo Kk ２β−置換チオメチルペニシリン誘導体
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
JP2603082B2 (ja) 1987-09-07 1997-04-23 大塚化学株式会社 ペニシラン酸誘導体の製造法
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
IT1227462B (it) 1988-11-04 1991-04-11 Glaxo Spa Procedimento di preparazione di 6-ossopenicillanati
TW383308B (en) 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
US5629306A (en) 1994-12-09 1997-05-13 Research Corporation Technologies, Inc. 7-alkylidene cephalosporanic acid derivatives and methods of using the same
US5597817A (en) 1994-12-09 1997-01-28 Southern Methodist University 7-vinylidene cephalosporins and methods of using the same
US5760027A (en) 1996-12-06 1998-06-02 Research Corporation Technologies, Inc. Use of 7-alkylidene cephalosporins to inhibit elastase activity
ATE219085T1 (de) 1997-12-29 2002-06-15 Res Corp Technologies Inc 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren
AU773013B2 (en) 1999-04-15 2004-05-13 Research Corporation Technologies, Inc. Beta-lactamase inhibiting compounds
US6391855B1 (en) * 1999-06-02 2002-05-21 Adherex Technologies, Inc. Compounds and methods for modulating junctional adhesion molecule-mediated functions
CA2454413A1 (en) * 2001-07-24 2003-03-13 Alamx, L.L.C. 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509351A (ja) * 2008-11-20 2012-04-19 プレジデント アンド フェローズ オブ ハーバード カレッジ 有機化合物のフッ素化

Also Published As

Publication number Publication date
DE60214740D1 (en) 2006-10-26
CA2454413A1 (en) 2003-03-13
DE60214740T2 (de) 2007-10-04
US7488724B2 (en) 2009-02-10
AU2002353768A1 (en) 2003-03-18
US20030092696A1 (en) 2003-05-15
US20060074065A1 (en) 2006-04-06
EP1430060B1 (en) 2006-09-13
WO2003020732A2 (en) 2003-03-13
US6916801B2 (en) 2005-07-12
WO2003020732A3 (en) 2003-05-22
ES2272795T3 (es) 2007-05-01
ATE339424T1 (de) 2006-10-15
EP1430060A2 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
JP2005502687A (ja) β−ラクタマーゼ阻害剤としての７−アルキリデン−３−置換型−３−セフェム−４−カルボキシラート
JPH05509089A (ja) セファロスポリンおよび同族体、製法および医薬組成物
US20060178357A1 (en) Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
JPH0559066A (ja) チオアルキルチオセフアロスポリン誘導体
JPWO1997037996A1 (ja) セフェム化合物及び該化合物を含有する医薬
JPS6322586A (ja) アシル誘導体
CA2282461C (en) 2-.beta.-substituted-6-alkylidene penicillanic acid derivatives as .beta.-lactamase inhibitors
AU773013B2 (en) Beta-lactamase inhibiting compounds
JP2000510854A (ja) β―ラクタム
US6407091B1 (en) β-lactamase inhibiting compounds
JPH11512737A (ja) 新規セフェム化合物
EP0831093A1 (en) 1-Carba-(dethia)-Cephalosporin Derivatives
EP1359153B1 (en) Beta-lactamase inhibiting compounds
US20030216372A1 (en) Inhibitors of serine and metallo-beta-lactamases
CH687205A5 (fr) Dérivés de thioalkylthiocarbacephalosporine.
US5939410A (en) 1-carba-(dethia)-cephalosporin derivatives
JP3218363B2 (ja) セフェム化合物、その製造方法及び該化合物を含む抗菌剤
JP2898054B2 (ja) セファロスポリン誘導体およびその製法
JPS62267228A (ja) 抗菌剤
JPS6019791A (ja) フルオロビニルチオオキサセフアロスポリン類
HK1009395A (en) 1-carba-(dethia)-cephalosporin derivatives
CZ163291A3 (cs) Nové beta«laktamové sloučeniny
JPH01203393A (ja) 新規セフアロスポリン系化合物
JPH06100568A (ja) セフェム化合物、その製造法およびその抗菌組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090210

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090630